ANIX
Price:
$2.91
Market Cap:
$99.01M
Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within the fields of oncology (cancer) and infectious diseases. Among its therapeutic pipeline, Anixa is developing a novel chimeric endocrine receptor T-cell (CER-T) technology, an innovative adaptation of CAR-T, specifically for ovarian cancer treatment. The company is also engaged in the discovery and development of antiviral drug candidates to combat COVID-19, focusing on the inhibition of specific viral protein functions. On the vaccine front, Anixa's initiatives include a vaccine designed to tar...[Read more]
Industry
Biotechnology
IPO Date
1983-10-07
Stock Exchange
NASDAQ
Ticker
ANIX
According to Anixa Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.79. This represents a change of 1.73% compared to the average of 9.62 of the last 4 quarters.
The mean historical Current Ratio of Anixa Biosciences, Inc. over the last ten years is 10.38. The current 9.79 Current Ratio has changed 9.33% with respect to the historical average. Over the past ten years (40 quarters), ANIX's Current Ratio was at its highest in in the July 2021 quarter at 30.67. The Current Ratio was at its lowest in in the January 2017 quarter at 0.56.
Average
10.38
Median
7.98
Minimum
4.11
Maximum
28.35
Discovering the peaks and valleys of Anixa Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 259.66%
Maximum Annual Current Ratio = 28.35
Minimum Annual Increase = -47.70%
Minimum Annual Current Ratio = 4.11
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 8.08 | -5.48% |
| 2024 | 8.54 | -31.66% |
| 2023 | 12.50 | -15.67% |
| 2022 | 14.83 | -47.70% |
| 2021 | 28.35 | 259.66% |
| 2020 | 7.88 | 91.62% |
| 2019 | 4.11 | -6.04% |
| 2018 | 4.38 | -44.48% |
| 2017 | 7.89 | 8.70% |
| 2016 | 7.25 | -37.54% |
The current Current Ratio of Anixa Biosciences, Inc. (ANIX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.71
5-year avg
14.46
10-year avg
10.38
Anixa Biosciences, Inc.’s Current Ratio is greater than Entera Bio Ltd. (7.93), greater than Inovio Pharmaceuticals, Inc. (1.04), greater than TuHURA Biosciences, Inc. (1.15), greater than Opus Genetics, Inc. (7.13), greater than Acumen Pharmaceuticals, Inc. (4.55), greater than VistaGen Therapeutics, Inc. (3.67), less than Seer, Inc. (17.73), less than Spero Therapeutics, Inc. (10.50), greater than Actuate Therapeutics Inc (1.80), greater than Agenus Inc. (0.38),
| Company | Current Ratio | Market cap |
|---|---|---|
| 7.93 | $59.64M | |
| 1.04 | $59.75M | |
| 1.15 | $163.66M | |
| 7.13 | $336.04M | |
| 4.55 | $136.90M | |
| 3.67 | $21.96M | |
| 17.73 | $95.67M | |
| 10.50 | $132.02M | |
| 1.80 | $49.53M | |
| 0.38 | $124.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anixa Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anixa Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Anixa Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Anixa Biosciences, Inc. (ANIX)?
What is the highest Current Ratio for Anixa Biosciences, Inc. (ANIX)?
What is the 3-year average Current Ratio for Anixa Biosciences, Inc. (ANIX)?
What is the 5-year average Current Ratio for Anixa Biosciences, Inc. (ANIX)?
How does the current Current Ratio for Anixa Biosciences, Inc. (ANIX) compare to its historical average?